AnalystsJack Allen
Jack Allen's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 1%
#5110 out of 5150 analysts
Average Return
-15.45%
Win Rate
37%15 out of 41
Risk vs Reward
Poor
Good

Jack Allen's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Instil Bio IncTIL
+137.60%$9.02$21.42
2024-01-17 -
2025-01-16
Buy
Instil Bio IncTIL
+119.12%$9.57$20.97
2024-01-19 -
2025-01-17
Buy
Arcellx IncACLX
+98.19%$29.30$58.07
2023-04-13 -
2024-04-12
Buy
Arcellx IncACLX
+87.26%$31.01$58.07
2023-04-14 -
2024-04-12
Buy
Renovacor IncRCOR
+82.86%$1.75$3.20
2022-09-13 -
2022-11-30
Buy

Jack Allen Analyst Color

Get additional color on Jack Allen's coverage of popular stocks

Jack Allen's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Crispr Therapeutics AgCRSP
3Hold$44.00-22.37%Maintains
a month ago
Vor Biopharma IncVOR
5Buy$64.00+411.59%Upgrades
2 months ago
Taysha Gene Therapies IncTSHA
5Buy$12.00+107.25%Maintains
2 months ago
Fate Therapeutics IncFATE
2Hold$4.00+247.83%Maintains
7 months ago
Allogene Therapeutics IncALLO
3Buy$9.00+496.03%Maintains
7 months ago
Carisma Therapeutics IncCARM
3Hold$1.00N/ADowngrades
a year ago
Mink Therapeutics IncINKT
2Buy$4.00N/AMaintains
a year ago
Arcellx IncACLX
5Buy$106.00N/AMaintains
a year ago
Intellia Therapeutics IncNTLA
2Hold$18.00N/AMaintains
a year ago
Instil Bio IncTIL
9Buy$180.00N/AReiterates
a year ago
Bluebird Bio IncBLUE
3Buy$120.00N/AMaintains
a year ago
Mereo Biopharma Group PLCMREO
1Buy$8.00N/AInitiates Coverage On
2 years ago
Immunocore Holdings PLCIMCR
1Buy$84.00N/AInitiates Coverage On
2 years ago
Korro Bio IncKRRO
3Hold$0.50N/ADowngrades
2 years ago
Decibel Therapeutics IncDBTX
2Hold$5.25N/ADowngrades
2 years ago
Lineage Cell Therapeutics IncLCTX
1Buy$5.00N/AInitiates Coverage On
3 years ago
Renovacor IncRCOR
1Buy$9.00N/AInitiates Coverage On
3 years ago
Cellectis SaCLLS
2BuyN/AN/AUpgrades
4 years ago
Voyager Therapeutics IncVYGR
1Buy$9.00N/AUpgrades
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.